Intended for healthcare professionals


Mifepristone: US Supreme Court rejects ban on abortion drug

BMJ 2024; 385 doi: (Published 14 June 2024) Cite this as: BMJ 2024;385:q1321
  1. Janice Hopkins Tanne
  1. New York

The US Supreme Court has unanimously rejected a case to restrict access to the abortion drug mifepristone. The Alliance for Hippocratic Medicine, an anti-abortion group in Texas, had asked the court to ban the drug and force the Food and Drug Administration to take it off the market. The case had been appealed from lower courts.1

On 13 June the Supreme Court rejected the case on technical grounds, stating that the alliance did not have legal standing to sue because doctors who were used as examples by the group to support its case were not harmed. They did not use or prescribe the drug or treat patients taking …

View Full Text

Log in

Log in through your institution


* For online subscription